Funding provides Bactolife with sufficient capital to commercialise its proprietary Binding Proteins™ and further strengthen its technology platform Financing was led by ATHOS, with participation from the Bill & Melinda Gates Foundation, and existing investors, incl. Novo Holdings, making…